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Abstract
Background:  Measures of multimorbidity are often applied to source data, populations or
outcomes outside the scope of their original developmental work. As the development of a
multimorbidity measure is influenced by the population and outcome used, these influences should
be taken into account when selecting a multimorbidity index. The aim of this study was to compare
the strength of the association of health-related quality of life (HRQOL) with three multimorbidity
indices: the Cumulative Illness Rating Scale (CIRS), the Charlson index (Charlson) and the
Functional Comorbidity Index (FCI). The first two indices were not developed in light of HRQOL.
Methods: We used data on chronic diseases and on the SF-36 questionnaire assessing HRQOL of
238 adult primary care patients who participated in a previous study. We extracted all the
diagnoses for every patient from chart review to score the CIRS, the FCI and the Charlson. Data
for potential confounders (age, sex, self-perceived economic status and self-perceived social
support) were also collected. We calculated the Pearson correlation coefficients (r) of the SF-36
scores with the three measures of multimorbidity, as well as the coefficient of determination, R2,
while controlling for confounders.
Results: The r values for the CIRS (range: -0.55 to -0.18) were always higher than those for the
FCI (-0.47 to -0.10) and Charlson (-0.31 to -0.04) indices. The CIRS explained the highest percent
of variation in all scores of the SF-36, except for the Mental Component Summary Score where
the variation was not significant. Variations explained by the FCI were significant in all scores of SF-
36 measuring physical health and in two scales evaluating mental health. Variations explained by the
Charlson were significant in only three scores measuring physical health.
Conclusion: The CIRS is a better choice as a measure of multimorbidity than the FCI and the
Charlson when HRQOL is the outcome of interest. However, the FCI may provide a good option
to evaluate the physical aspect of HRQOL for the ease in its administration and scoring. The
Charlson index may not be recommended as a measure of multimorbidity in studies related to
either physical or mental aspects of HRQOL.
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Background
The coexistence of multiple chronic diseases in the same
individual or multimorbidity has led to increasing interest
in its measure in research studies as a potential con-
founder or as a predictor of study outcome [1,2].
Health-related quality of life (HRQOL) is an outcome
measure that is adversely affected by the presence of mul-
timorbidity. This association can be demonstrated using
the simple count of chronic conditions as a measure of
multimorbidity [3-8]. However, we found in a recent
study that the use of a multimorbidity index, the Cumula-
tive Illness Rating Scale (CIRS), revealed a stronger associ-
ation of HRQOL with multimorbidity than a simple
count of chronic diseases [8]. Measures of multimorbidity
are often applied to source data, populations or outcomes
outside the scope of the original developmental work [9].
However, as the development of a multimorbidity meas-
ure is influenced by the population and outcome used,
these influences should be taken into account when
selecting a multimorbidity index [10]. Although the CIRS
is a comprehensive evaluation of medical problems by
organ system, it was not developed in light of HRQOL.
Therefore, it can be argued that another measure of multi-
morbidity (or comorbidity if an index disease is the object
of study) specifically designed for HRQOL could bear a
stronger relationship with HRQOL than the CIRS, and
would be a better measure of multimorbidity when the
outcome of interest is HRQOL.
Several indices have been described to measure multimor-
bidity or comorbidity [1,2,11]. However, some problems
related to many of these indices have been reported such
as insufficient data on their clinimetric properties and
moderate inter-rater reliability [2,12]. Two indices stand
out as potential alternatives to the CIRS, the Charlson
Index and the Functional Comorbidity Index (FCI). The
Charlson index [13] is, with the CIRS [14], among the
most valid and reliable measures of multimorbidity [2].
The Charlson index is the most extensively studied comor-
bidity index and, although the weights originally used to
develop it were based on the relative risk of dying, it has
been found to significantly predict the number of ambu-
latory visits, the probability of an inpatient admission, the
length of stay, and hospital costs [9,15]. However, the
association between the Charlson index and HRQOL has
been assessed only in patients of age 65 or older [16].
Recently developed, the Functional Comorbidity Index
(FCI) [11] was specifically developed with physical func-
tioning, an aspect of HRQOL, as the validity criterion. The
index was developed using two databases totalizing
37,772 Canadian and US adults seeking treatment for
spine ailments. It is possible that the association of this
index with physical aspects of HRQOL could outperform
the CIRS, but this hypothesis has not been tested yet.
Using these three indices (CIRS, FCI and Charlson) on the
same target population would allow a better comparison
of their performance when the outcome of interest is
HRQOL, but we could not find any study with such com-
parison. Thus, the primary purpose of this study was to
compare the strength of the association of the CIRS, the
Charlson index and the FCI measures of multimorbidity,
with HRQOL.
Methods
We used data collected on the diagnoses of chronic dis-
eases in a group of 238 adult primary care patients (age 18
or older) who participated in a study on HRQOL [8].
Patients were recruited from the clientele of 21 family
physicians in the Saguenay region, Canada. Details of the
sampling are described elsewhere [17]. In brief, we ran-
domly selected patients from 980 patients who had also
been selected at random for a prevalence study on multi-
morbidity [17]. Our goal was to recruit 60 patients for
each CIRS quintile to have enough representation of dif-
ferent levels of multimorbidity. Of the 419 patients we
tried to contact by phone, 66 could not be reached,
despite repeated attempts. Of the remaining 353 patients,
238 agreed to participate (Table 1). Patients completed
the self-administered 36-item short form of the Medical
Outcomes Study questionnaire (SF-36) [18] to assess
HRQOL. The SF-36 comprises 8 multi-item scales divided
into 2 main groups: physical and mental aspects of quality
of life. Two summary scores for each group are obtained
through a weighted sum of these scales. To compute the
Physical Component Summary scale, high positive
weights are given to the scales of the physical aspects of
quality of life and low negative weights to those of the
mental health. To calculate the Mental Component Sum-
Table 1: Characteristics of the Sample
Characteristic Refusals (n = 115) Participants (n = 238) P value
Mean (SD) age, y 56.5 (17.4) 59.0 (14.3) 0.17*
Mean (SD) diagnoses, n 5.5 (3.2) 5.3 (2.8) 0.49*
Male, % 33.9 29.0 0.39†
*t-test.
†Chi-square test.Health and Quality of Life Outcomes 2005, 3:74 http://www.hqlo.com/content/3/1/74
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mary scale, low negative weights are given to the scores of
the physical aspects of quality of life and high positive
weights are given to those of the mental health. For all
scales and both summary scales, lower scores indicate
lower HRQOL.
From an exhaustive chart review, we extracted a compre-
hensive list of diagnoses of all chronic conditions for
every patient after informed consent. We then used the list
to score the CIRS [19], the FCI [11] and the Charlson
index [13] (Table 2). To obtain the most reliable measures
for analysis, the three indices were scored by two investi-
gators independently in a group of patients (the number
of patients varied from 49 to 73 for the 3 indices), and
inter-rater reliability was calculated. During a standardiza-
tion period, the scoring process was discussed to reach a
consensus and repeated until the inter-rater reliability was
judged acceptable [20].
Data for potential confounders (age, sex, self-perceived
economic status and self-perceived social support) were
also collected. Self-perceived social support was measured
with the Social Provisions Scale [21]. The research ethics
board of the Centre de santé et de services sociaux de
Chicoutimi approved this study.
Statistical analysis
To investigate the relationship between HRQOL and the
multimorbidity indices as well as the direction of the rela-
tionships (positive or negative), we first calculated the
Pearson correlation coefficients of the SF-36 scores with
the three measures of multimorbidity. We also compared
CIRS correlation coefficients with those of the FCI and the
Charlson index [22]. Next, the coefficient of determina-
tion, R2, was calculated to measure the percentage of vari-
ation in the dependent variables (all SF-36 scales and two
SF-36 summary scores) explained by each measure of
multimorbidity over and above that explained by age,
gender, self-perceived social support and self-perceived
economical status. We obtained these estimates through
multiple regression analysis for which underlying
assumptions were judged satisfactory. All analyses were
done using the SAS system for Windows (version 8.02,
SAS Institute, Inc, Cary, NC, USA).
Table 2: Main characteristics of CIRS, FCI and Charlson†
Comorbidity indices CIRS FCI Charlson
Items 1. Cardiac
2. Vascular
3. Hematological
4. Respiratory
5. Ophthalmological and ORL
6. Upper gastrointestinal
7. Lower gastrointestinal
8. Hepatic and pancreatic
9. Renal
10. Genitourinary
11. Musculoskeletal and tegumental
12. Neurological
13. Endocrine, metabolic, breast
14. Psychiatric
1. Arthritis (rheumatoid and 
osteoarthritis)
2. Osteoporosis
3. Asthma
4. COPD, ARDS*
5. Angina
6. Congestive heart failure or heart 
disease
7. Heart attack
8. Neurological disease
9. Stroke or transient ischemic attack
10. Diabetes types I and II
11. Peripheral vascular disease
12. Upper gastrointestinal disease
13. Depression
14. Anxiety or panic disorders
15. Visual impairment
16. Hearing impairment
17. Degenerative disk disease
18. Obesity and/or BMI > 30 kg/m2
1. Myocardial infarct
2. Congestive heart failure
3. Peripheral vascular disease
4. Cerebrovascular disease
5. Dementia
6. Chronic pulmonary disease
7. Connective tissue disease
8. Ulcer disease
9. Stroke or transient ischemic attack
10. Diabetes
11. Hemiplegia
12. Moderate or severe renal disease
13. Diabetes with end organ damage
14. Any tumor
15. Leukemia
16. Lymphoma
17. Moderate or severe liver disease
18. Metastatic solid tumor
19. AIDS
Weights All systems weighted from 0 to 4:
0 No problem
1 Mild
2 Moderate
3 Severe
4 Extremely severe
Presence (yes) or absence (no) of 
diagnoses
Conditions from 1 to 10, weight = 1
Conditions from 11 to 16, weight = 2
Condition 17, weight = 3
Conditions 18 and 19, weight = 6
Final score Sum of weights assigned to each 
system
Sum of "yes" answers Sum of weights assigned to each 
condition that a patient has
† CIRS = Cumulative Illness Rating Scale; FCI = Functional Comorbidity Index; Charlson = Charlson index.
* COPD = chronic obstructive pulmonary disease; ARDS = acquired respiratory distress syndromeHealth and Quality of Life Outcomes 2005, 3:74 http://www.hqlo.com/content/3/1/74
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Results
After standardization of the scoring process, the intraclass
correlation coefficients for the inter-rater reliability were
0.96, 0.92 and 0.90 for the CIRS, the FCI and the Charlson
respectively.
Figure 1 shows the distribution of each multimorbidity
score. The CIRS had the widest variation, with a range of
1 to 27 with a mode of 9 (mean = 10.3). The FCI had a
range of 0 to 8, with a mode of 3 (mean = 2.4). The Charl-
son index had a similar range (0–7) but a different distri-
bution from that of the FCI, with 120 patients (50.4%)
having a score of zero (mean = 0.9).
Pearson correlation coefficients of SF-36 with the three
measures of multimorbidity are shown in Table 3. The
CIRS was negatively correlated with all scales of SF-36
except the Mental Component Summary; i.e. higher mor-
bidity or multimorbidity level was associated with lower
HRQOL. The FCI was negatively correlated with all SF-36
scales measuring the physical aspect of HRQOL; it was
also negatively correlated with two scales measuring the
mental aspect of HRQOL. The Charlson index was nega-
tively correlated with all scales of SF-36 evaluating the
physical aspect of HRQOL; it was not correlated with any
of the scales evaluating the mental aspect. There was an
unexpected positive correlation of the Charlson index
with the Mental Component Summary that did not have
any meaningful interpretation. The CIRS correlation coef-
ficients were significantly different from those of the FCI
for the SF-36 scales of Physical Functioning, Role Physical
and Social Functioning as well as for the Physical Compo-
nent Summary; whereas the Charlson correlation coeffi-
cients were significantly different from those of CIRS for
all SF-36 scales.
Table 4 shows the percentage of variation in HRQOL
explained by each measure of multimorbidity over and
above that explained by age, gender, self-perceived social
support and economic status. The CIRS explained the
highest percent of variation in all scores, except for the
Mental Component Summary score where the explained
variation was not significant.
Discussion
We compared the strength of association of three multi-
morbidity indices (CIRS, FCI and Charlson index) with
HRQOL as the outcome of interest in a primary care con-
text. In terms of percent of explained variation in HRQOL,
the CIRS performed as well as and often better than the
FCI and the Charlson index in all scores of the SF-36. Cor-
relation coefficients of the SF-36 scores with the measures
of multimorbidity were always higher for the CIRS, fol-
lowed by the FCI (Table 3); the correlations of the SF-36
scores with the Charlson index were always the weakest.
We also found an unexpected positive correlation of the
Charlson index with the SF-36 Mental Component Sum-
mary.
Among the three indices, the CIRS was the one that
explained the highest percent of variation in all scores of
the SF-36. Despite the fact that the FCI was developed
with physical function as the outcome of interest, it did
not perform better than the CIRS in any of the scales of the
SF-36 evaluating the physical aspect of HRQOL. This
result may be due in part to the wider range of possible
scores on the CIRS. Indeed, an index ranging from 0 to 27
can better predict variations in an outcome than one that
ranges from 0 to 7 or 8 with more than half the patients
Table 3: Pearson correlation coefficients of the SF-36† scores 
with the measures of multimorbidity
HRQOL (SF-36) Correlation coefficients (r)
Physical Health CIRS‡ FCI Charlson
Physical Functioning -0.55** -0.47** -0.31**
Role physical -0.41** -0.32** -0.14*
Bodily Pain -0.38** -0.33** -0.16*
General Health -0.40** -0.34** -0.21**
Mental Health
Vitality -0.30** -0.23** -0.08
Social Functioning -0.29** -0.21** -0.04
Role Emotional -0.18** -0.10 +0.03
Mental Health -0.18** -0.14** +0.07
Physical Component Summary -0.54** -0.47** -0.31**
Mental Component Summary -0.06 -0.001 +0.16*
† SF-36 = Self-administered 36-item short form of the Medical 
Outcomes Study questionnaire.
‡ CIRS = Cumulative Illness Rating Scale; FCI = Functional 
Comorbidity Index; Charlson = Charlson index. * p < 0.05; ** p < 
0.01
Distribution of scores on multimorbidity measures Figure 1
Distribution of scores on multimorbidity measures. CIRS = 
Cumulative Illness Rating Scale; FCI = Functional Comorbid-
ity Index; Charlson = Charlson index.
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being classified in the first 2 or 3 levels of the scale. It may
also be due to the fact that the CIRS evaluates the number
and severity of all chronic diseases whereas the FCI evalu-
ates a limited number of diagnoses and does not take into
account disease severity. However, R2 values for the FCI
related to physical health scores, although lower than
those of the CIRS, remained highly significant after con-
trolling for confounders. Given that the FCI is very easy to
administer and score, researchers may consider, depend-
ing on the characteristics of the study, to trade off a lower
explained variation for simplicity to evaluate the physical
aspect of HRQOL. In the case of the Charlson index, the
percent of explained variation was significant only in the
Physical Functioning, the General Health, and the Physi-
cal Component Summary scales. In the mental aspect of
HRQOL, the percent of variation explained by the Charl-
son index was not significant in any of the scales of the SF-
36. Given these results, the Charlson index may not be
recommended as a measure of multimorbidity in HRQOL
studies in adults.
The FCI was the only index of multimorbidity that we
were aware of that was developed using a component of
HRQOL (Physical Functioning) as outcome. However,
two other articles reporting multimorbidity measures
related with HRQOL were published upon completion of
the present study. One of the articles describes a new self-
reported assessment of comorbidity, or self-reported dis-
ease burden [16]; the other article describes five indices or
approaches to scoring multimorbidity derived from a self-
administered multimorbidity questionnaire [23].
In the article on the self-reported disease burden [16], the
index was validated using two scales of the SF-36 evaluat-
ing the physical aspect of HRQOL (Physical Functioning
and one item of General Health) as well as the outcomes
of depression and self-efficacy. The authors studied these
outcomes using the Charlson index and the findings were
similar to ours. They found a negative correlation between
the Charlson index and the Physical Functioning and
General Health outcomes [16]. However, our study
expanded the analysis of the Charlson index to all scales
of the SF-36 evaluating both physical and mental aspects
of the HRQOL. Moreover, we included adults aged 18 and
over, whereas age was restricted to 65 years or older in the
study on the self-reported disease burden [16]. In the sec-
ond paper by Byles et al [23], the study was a comparison
of the performance of five indices derived from a self-
administered multimorbidity questionnaire. None of the
indices was compared to other indices previously pub-
lished. Unfortunately, it was not possible to include these
five indices in our comparative study because of the chart
review method that we used. However, future research
comparing CIRS with these five indices as well as with the
self-reported disease burden index is warranted.
In our analysis of the relationship between mental aspects
of HRQOL and multimorbidity, we found some contra-
dictory results that may reflect a limitation in our instru-
Table 4: Percentage of variation of the SF-36  scores explained by each measure of multimorbidity
HRQOL (SF-36) Percentage of variation 
explained by the 
control variables†
Partial R2(%)‡
Physical Health CIRS§ FCI Charlson
Physical Functioning 21.08** 15.59** 9.53** 4.52**
Role physical 7.84** 11.14** 5.21** 0.56
Bodily Pain 10.02** 9.91** 6.80** 1.04
General Health 11.63** 14.07** 7.96** 2.99**
Mental Health
Vitality 10.68** 6.78** 2.56* 0.10
Social Functioning 10.77** 6.72** 2.94** 0.002
Role Emotional 6.71** 2.64* 0.43 0.52
Mental Health 17.07*** 2.26* 1.02 1.18
Physical Component 
Summary
13.18** 17.75** 11.81** 5.46**
Mental Component 
Summary
12.60** 0.75 0.02 2.80
 SF-36 = Self-administered 36-item short form of the Medical Outcomes Study questionnaire.
† control variables: age, gender, self-perceived social support and self-perceived economical status
‡ controlling for age, gender, self-perceived social support and self-perceived economical status.
§CIRS = Cumulative Illness Rating Scale; FCI = Functional Comorbidity Index; Charlson = Charlson index.
* p < 0.05 ; ** p < 0.01Health and Quality of Life Outcomes 2005, 3:74 http://www.hqlo.com/content/3/1/74
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ments. All scales of the SF-36 used to measure the mental
aspect of HRQOL were related to the CIRS, whereas the
Mental Component Summary was not (Tables 3 and 4).
This summary score was created by the developers of the
SF-36 with the hope to reduce the number of statistical
comparisons involved in analyzing the SF-36 without
substantial loss of information [24]. The lowest possible
score of the Mental Component Summary indicates fre-
quent psychological distress, social disability due to emo-
tional problems, and a poorly self-rated health [24].
However, the lack of relationship we found between the
CIRS and the Mental Component Summary contradicts
the relationship we found between the CIRS and all men-
tal scales of the SF-36 of which the Mental Component
Summary is a composite. One possible explanation may
be that the calculation of the Mental Component Sum-
mary takes into account not only the four scales measur-
ing mental health, but also the four scales measuring
physical health which are weighted negatively [25]. As a
result, the positive weights of the mental health scales
may be canceled out by the negative weights of the physi-
cal health scales which have a stronger relationship with
the CIRS in our study. This problem was evident in the
relationship between the CIRS and the Mental Compo-
nent Summary, but it also affected the relationships
between this summary score and the other measures of
multimorbidity. These results suggest that the Mental
Component Summary produced a substantial loss of
information in the context of our study.
Conclusion
In summary, our study suggests that the CIRS is a better
choice as a measure of multimorbidity than the FCI and
the Charlson index in a primary care context when
HRQOL is the outcome of interest. However, if research-
ers were interested only in the physical aspect of HRQOL,
then the FCI, despite its lower explained variation in
HRQOL, may provide a good option for the ease in its
administration and scoring. Finally, based on our results,
the Charlson index may not be recommended as a meas-
ure of multimorbidity in studies related to either physical
or mental aspects of HRQOL.
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